ARCHIVES

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

This article is from The Cancer Letter archive.

Vol. 39 No. 42 | November 8, 2013

Download PDF Visit The Full Archive

Related Articles

OAM Director Jacobs To Leave; Cites “Conflict with Conscience”

July 15, 1994

AACR Plans Office in Singapore.

November 30, 2007

NCI-Approved Trials Listed

March 30, 2007

NCI-Approved Clinical Trials

November 26, 2004

Stronger Measures Needed To Reduce U.S. Smoking, IOM Says.

June 1, 2007

CIS Cost Sharing Feasibility Study Recommended

December 11, 1987